Phase II trial of TS-1 and cisplatin in patients with Carcinoma of Unknown Primary Sites.
Phase of Trial: Phase II
Latest Information Update: 28 Feb 2017
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Cisplatin
- Indications Cancer
- Focus Therapeutic Use
- 27 Feb 2017 Status changed from recruiting to completed.
- 10 Sep 2008 New trial record.